494 related articles for article (PubMed ID: 29696467)
1. Ocular sebaceous gland carcinoma: an update of the literature.
Cicinelli MV; Kaliki S
Int Ophthalmol; 2019 May; 39(5):1187-1197. PubMed ID: 29696467
[TBL] [Abstract][Full Text] [Related]
2. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
4. Ocular Sebaceous Carcinoma In Situ With Biphenotypic Differentiation: A Reappraisal of the Alternative Origin of the Tumor.
Yim CL; Lam SC; Yuen HKL; Cheuk W
Int J Surg Pathol; 2020 Dec; 28(8):888-892. PubMed ID: 32363990
[TBL] [Abstract][Full Text] [Related]
5. Reverse masquerade: primary eyelid amyloidosis mimicking sebaceous gland carcinoma.
Shahid Alam M
Orbit; 2022 Jun; 41(3):392. PubMed ID: 33779482
[No Abstract] [Full Text] [Related]
6. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
7. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
8. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
[TBL] [Abstract][Full Text] [Related]
9. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
10. Collision tumor of sebaceous carcinoma and squamous cell carcinoma of the eyelid: Case report.
Wang JJ; Lee KF; Chen CY
Eur J Ophthalmol; 2022 Sep; 32(5):NP55-NP59. PubMed ID: 34011202
[TBL] [Abstract][Full Text] [Related]
11. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous carcinoma.
Nelson BR; Hamlet KR; Gillard M; Railan D; Johnson TM
J Am Acad Dermatol; 1995 Jul; 33(1):1-15; quiz 16-8. PubMed ID: 7601925
[TBL] [Abstract][Full Text] [Related]
13. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
14. Sebaceous Carcinoma: Clinicopathologic Analysis of 29 Cases in a Tertiary Hospital in Korea.
Park SK; Park J; Kim HU; Yun SK
J Korean Med Sci; 2017 Aug; 32(8):1351-1359. PubMed ID: 28665073
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous carcinoma presenting as a unilateral papillary conjunctivitis.
Gloor P; Ansari I; Sinard J
Am J Ophthalmol; 1999 Apr; 127(4):458-9. PubMed ID: 10218701
[TBL] [Abstract][Full Text] [Related]
17. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Bakhshi S; Pushker N; Sharma A; Kashyap S; Bajaj MS; Singh VK
Br J Ophthalmol; 2020 Jun; 104(6):879-884. PubMed ID: 30940620
[TBL] [Abstract][Full Text] [Related]
18. [Eyelid sebaceous carcinoma. A case report with literature review].
Laxenaire A; Saihi E; Huault M; Levy J
Ann Chir Plast Esthet; 2000 Feb; 45(1):48-57. PubMed ID: 10783512
[TBL] [Abstract][Full Text] [Related]
19. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
20. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.
Cook BE; Bartley GB
Ophthalmology; 2001 Nov; 108(11):2088-98; quiz 2099-100, 2121. PubMed ID: 11713084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
